![]() |
市场调查报告书
商品编码
1662781
2030 年蛋白胨市场预测:依来源、形式、应用、最终用户、地区进行全球分析Peptone Market Forecasts to 2030 - Global Analysis By Source (Plant Peptone, Animal Peptone, Microbial Peptone and Other Sources), Form, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球蛋白胨市场规模预计在 2024 年达到 1.5263 亿美元,到 2030 年将达到 2.1572 亿美元,预测期内复合年增长率为 6.5%。
蛋白胨是透过蛋白质部分水解而获得的胜肽和胺基酸的水溶性混合物。它常用于微生物学和生物化学研究中,作为培养细菌、酵母菌和其他微生物的营养源。它提供氮、碳和胺基酸等必需的生长因子,这些因子对于实验室培养中的微生物代谢和生长至关重要。蛋白胨常见于微生物生长实验所使用的培养基。
根据印度品牌资产基金会统计,印度目前拥有5,000家生技公司,其中760家为核心公司,4,240家为新兴企业。预计到 2024 年将达到约 10,000。
个人化医疗需求日益增长
蛋白胨是用于生物製药(包括个人化治疗)开发和生产的细胞培养基的重要组成部分。精准医疗强调根据个人基因图谱实施个人化治疗,这推动了对专业化、高品质细胞培养环境的需求。蛋白胨是支持细胞生长和蛋白质生产所需的营养素。这种对更有针对性和客製化治疗的需求直接增加了对蛋白胨的需求,刺激了生物技术和製药领域的市场扩张。
环境和道德问题
植物来源的蛋白胨引发了环境和道德问题,尤其是在使用动物源蛋白胨方面。问题包括动物福利、资源使用和潜在的污染风险。原料采购过程中产生的森林砍伐和用水都会对环境造成影响。道德问题主要集中在动物治疗和生产的永续性。这些替代品可能会减少对传统蛋白胨来源的依赖并限制某些行业的需求。
微生物生物技术进展
随着微生物生物技术的进步,蛋白胨的生产将变得更加高效和具有成本效益,从而可以从各种来源生产高品质的蛋白胨。这项进步使得製药、食品和饮料等产业以及生物基产品生产的发酵过程得到最佳化。此外,生物技术的创新推动了植物来源的合成和重组蛋白胨的开发,满足了对永续和道德的替代品日益增长的需求。这些进步扩大了蛋白胨的应用和可用性,进一步推动了市场的成长。
替代产品的可用性
蛋白胨的替代品包括植物来源、酵母萃取物和化学成分明确的培养基。这些替代品具有降低动物源污染物风险和提高一致性等优点。此外,替代品可以满足人们对纯素和无残忍产品日益增长的需求,从而鼓励人们摆脱传统的蛋白胨。这种竞争,加上对监管部门核准和替代品生产可扩展性的担忧,可能会减缓蛋白胨的市场扩张。
COVID-19 疫情对蛋白胨市场产生了多方面的影响。虽然由于生物技术和製药研究的活性化,特别是在疫苗开发和诊断测试方面的研究,对蛋白胨的需求激增,但市场也面临挑战。此外,一些研究计划已暂时停止,影响了市场成长。儘管存在这些挫折,但在研究主导的蛋白胨需求强劲成长的推动下,整体市场仍表现出弹性。
预测期内,蛋白胨水市场预计将成长至最大
预计预测期内蛋白胨部分将占据最大的市场占有率。蛋白胨水是一种营养丰富的液体培养基,主要用于微生物学研究和诊断应用。它含有来自肉类和植物等蛋白质来源的蛋白胨,可提供细菌和真菌培养所必需的必需氨基酸和生长因子。它能够支持多种微生物,这使得它成为任何微生物学实验室的重要组成部分。
预计预测期内发酵部分将以最高的复合年增长率成长。
预计预测期内发酵部分将呈现最高的成长率。蛋白胨是发酵应用中不可或缺的成分,也是微生物生长所必需的胺基酸、胜肽和维生素的丰富来源。支持微生物在酵素、抗生素和生质燃料等生物基产品生产的开发。它在製药、生物技术和食品生产等行业中发挥着重要作用,因为它对于高效的发酵过程至关重要。
预计预测期内亚太地区将占据最大的市场占有率。这是因为生物技术、製药和研究领域对高品质胜肽的需求不断增加。中国、日本、印度、韩国和东南亚等地区以其快速发展的医疗保健和生物技术领域而闻名,推动了对胜肽生产的投资不断增长。主要企业包括生物技术公司和多肽製造商,例如 Sigma-Aldrich、Peptide Synthetics 和 Bachem,他们凭藉创新产品和服务主导着该地区。
在预测期内,受生物技术和生物製药领域蓬勃发展的推动,北美预计将呈现最高的复合年增长率。该地区是主要企业的所在地,包括赛默飞世尔科技、默克集团和 Soravia 集团。该地区成熟的研究基础设施,加上在生命科学和医疗保健领域的大量投资,为北美蛋白胨市场的持续成长提供了肥沃的土壤。
According to Stratistics MRC, the Global Peptone Market is accounted for $152.63 million in 2024 and is expected to reach $215.72 million by 2030 growing at a CAGR of 6.5% during the forecast period. Peptone is a water-soluble mixture of peptides and amino acids derived from the partial hydrolysis of proteins. It is commonly used in microbiological and biochemical research as a nutrient source for cultivating bacteria, yeast, and other microorganisms. They provide essential growth factors, such as nitrogen, carbon, and amino acids, which are vital for the metabolism and proliferation of microorganisms in laboratory cultures. Peptones are frequently found in culture media for microbial growth experiments.
According to the India Brand Equity Foundation, there are currently 5,000 biotech businesses in the country, of which, 760 are core businesses and 4,240 are start-ups. By 2024, it is anticipated that there will be about 10,000 businesses.
Rising demand for personalized medicine
Peptones are essential components in cell culture media used for the development and production of biopharmaceuticals, including personalized therapies. As personalized medicine focuses on tailoring treatments based on individual genetic profiles, there is an increasing need for specialized, high-quality cell culture environments. Peptones provide the necessary nutrients to support cell growth and protein production. This demand for more targeted and customized therapies directly increases the need for peptones, fueling market expansion in the biotechnology and pharmaceutical sectors.
Environmental and ethical issues
Peptones, derived from animal or plant sources, raise environmental and ethical concerns, particularly regarding the use of animal-derived peptones. Issues include animal welfare, resource use, and potential contamination risks. Environmental impacts stem from deforestation and water usage associated with sourcing materials. Ethical concerns center on the treatment of animals and the sustainability of production. These alternatives may reduce reliance on traditional peptone sources, limiting demand in certain industries.
Advancements in microbial biotechnology
As microbial biotechnology improves, the production of peptones becomes more efficient and cost-effective, enabling the creation of high-quality peptones from various sources. This progress allows for better optimization of fermentation processes in industries like pharmaceuticals, food, and beverages, as well as in the production of bio-based products. Additionally, biotechnology innovations enable the development of plant-based, synthetic, or recombinant peptones, catering to growing demands for sustainable and ethical alternatives. These advancements expand the applications and availability of peptones, further driving market growth.
Availability of alternatives
Alternatives to peptones include plant-based extracts, yeast extracts, and chemically defined media. These alternatives offer advantages like reduced risk of animal-derived contaminants and greater consistency. Additionally, alternatives may cater to the growing demand for vegan and cruelty-free products, prompting industries to shift away from traditional peptones This competition, coupled with concerns over regulatory approvals and production scalability of alternatives, can slow down the market expansion for peptones.
The covid-19 pandemic had a mixed impact on the peptone market. While the demand for peptones surged due to increased biotechnology and pharmaceutical research, especially for vaccine development and diagnostic tests, the market also faced challenges. Additionally, some research projects were temporarily halted, affecting market growth. Despite these setbacks, the overall market showed resilience with a significant increase in research-driven demand for peptones.
The peptone water segment is expected to be the largest during the forecast period
The peptone segment is expected to account for the largest market share during the forecast period. Peptone water is a nutrient-rich liquid medium used primarily in microbiological research and diagnostic applications. It contains peptones, which are derived from protein sources like meat or plant matter, providing essential amino acids and growth factors for bacterial and fungal cultivation. Its ability to support a wide range of microorganisms makes it vital in microbiology laboratories.
The fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the fermentation segment is predicted to witness the highest growth rate. Peptone is a vital ingredient in fermentation applications, serving as a rich source of amino acids, peptides, and vitamins essential for microbial growth. It supports the development of microorganisms in the production of bio-based products like enzymes, antibiotics, and biofuels. Its role is critical in industries such as pharmaceuticals, biotechnology, and food production, making it indispensable for efficient fermentation processes.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to the rising demand for high-quality peptides used in biotechnology, pharmaceuticals, and research. Regions such as China, Japan, India, South Korea, and Southeast Asia are well known for their rapidly developing healthcare and biotech sectors, contributing to increased investment in peptide production. Key players including biotechnology firms, and peptide manufacturers, such as Sigma-Aldrich, Peptide Synthetics, and Bachem, dominates the regional landscape with innovative products and services.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the thriving biotechnology and biopharmaceutical sectors. The region is home for several key players such as Thermo Fisher Scientific, Merck KGaA, and Solabia Group which dominate the market. The region's well-established research infrastructure, coupled with significant investments in life sciences and healthcare, provides a fertile ground for the continued growth of the North American peptone market.
Key players in the market
Some of the key players in Peptone market include Thermo Fisher Scientific, Merck KGaA, Sigma-Aldrich, BD Biosciences, Neogen Corporation, HiMedia Laboratories, DuPont, Hardy Diagnostics, MP Biomedicals, Proliant Biologicals, Kerry, Inc., Solabia Group, Global BioIngredients Inc., Titan Biotech Limited, Biotecnica, Wako Pure Chemical Industries and Nu-Tek BioSciences.
In September 2024, Nu-Tek BioSciences launched two new versions of their Soy Peptone, specifically designed to meet the diverse needs of cell culture media applications. These new offerings expand Nu-Tek's portfolio of animal-free, non-GMO soy peptones, which are widely used in microbiological media, fermentation nutrient systems, and cell culture media.
In November 2021, Biotecnica introduced a new line of low endotoxin peptones. Biotecnica's new line of low endotoxin peptones eliminates the need for ultrafiltration, making the process more efficient and cost-effective. This development could help Biotecnica stand out in the competitive market of peptone suppliers by offering a product that addresses both technical and economic challenges in cell culture and microbiology applications.